Voloridge Investment Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-109,953
| Closed | -$1.03M | – | 1271 |
|
|
2024
Q3 | $1.03M | Sell |
109,953
-2,381,706
| -96% | -$22.4M | ﹤0.01% | 1018 |
|
|
2024
Q2 | $20M | Sell |
2,491,659
-1,002,525
| -29% | -$8.04M | 0.07% | 369 |
|
|
2024
Q1 | $51.8M | Buy |
3,494,184
+2,511,104
| +255% | +$37.2M | 0.19% | 152 |
|
|
2023
Q4 | $7.99M | Buy |
983,080
+782,656
| +391% | +$6.36M | 0.03% | 522 |
|
|
2023
Q3 | $912K | Sell |
200,424
-329,718
| -62% | -$1.5M | ﹤0.01% | 1116 |
|
|
2023
Q2 | $3.73M | Sell |
530,142
-598,771
| -53% | -$4.22M | 0.02% | 777 |
|
|
2023
Q1 | $6.9M | Sell |
1,128,913
-581,929
| -34% | -$3.56M | 0.03% | 568 |
|
|
2022
Q4 | $10.9M | Buy |
1,710,842
+267,794
| +19% | +$1.71M | 0.06% | 405 |
|
|
2022
Q3 | $13.8M | Buy |
1,443,048
+437,941
| +44% | +$4.2M | 0.07% | 356 |
|
|
2022
Q2 | $11.1M | Buy |
1,005,107
+259,895
| +35% | +$2.87M | 0.06% | 406 |
|
|
2022
Q1 | $12.4M | Buy |
745,212
+141,536
| +23% | +$2.36M | 0.07% | 351 |
|
|
2021
Q4 | $11.5M | Sell |
603,676
-34,758
| -5% | -$664K | 0.06% | 425 |
|
|
2021
Q3 | $15.7M | Sell |
638,434
-55,183
| -8% | -$1.36M | 0.1% | 273 |
|
|
2021
Q2 | $18M | Buy |
693,617
+609,506
| +725% | +$15.9M | 0.13% | 213 |
|
|
2021
Q1 | $2.66M | Buy |
84,111
+47,800
| +132% | +$1.51M | 0.02% | 716 |
|
|
2020
Q4 | $1.69M | Buy |
+36,311
| New | +$1.69M | 0.01% | 797 |
|